The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Is The Anticipated Rise In Market Value Of The Deep Vein Thrombosis Market During The Forecast Period?
The market for deep vein thrombosis has experienced consistent expansion over the last few years. Forecasts indicate it will expand from $1.09 billion in 2025 to reach $1.14 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 4.0%. This historical expansion is largely due to factors such as a greater occurrence of venous thromboembolism, an older demographic adopting inactive lifestyles, an increase in surgical procedures performed in hospitals, enhanced access to traditional anticoagulants, and heightened awareness regarding DVT complications.
The deep vein thrombosis market is projected to experience consistent expansion over the upcoming period. This market is anticipated to reach a valuation of $1.37 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 4.7%. Several factors are driving this anticipated growth, including progress in new anticoagulant therapies, a rising preference for oral medications over injectables, the broadening of homecare and remote monitoring services, an increase in preventive screening initiatives, and enhanced accessibility via online pharmacies. Key trends expected during this period involve the increasing uptake of direct oral anticoagulants, a move towards managing DVT in outpatient and home settings, a greater emphasis on early detection and risk assessment, the growing application of minimally invasive interventional techniques, and the expansion of online and specialized pharmacy distribution channels.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10616&type=smp
Which Drivers Are Supporting The Deep Vein Thrombosis Market Growth?
The growing population needing deep vein thrombosis (DVT) treatment is anticipated to drive expansion in the deep vein thrombosis market in the future. DVT treatment involves managing patients suffering from deep vein thrombosis through medications like anticoagulants and other agents. These treatments work by stopping new blood clots from forming and preventing existing ones from expanding, thereby improving the patient’s condition. This rise in patients needing DVT care suggests a higher incidence of deep vein thrombosis, creating a demand for diagnostic, preventive, and therapeutic products. For example, data from February 2023, released by the Centers for Disease Control and Prevention (CDC), a US national public health organization, indicated that approximately 900,000 individuals in the United States might be impacted annually by deep vein thrombosis. Furthermore, DVT or pulmonary embolism (PE) is responsible for 60,000 to 100,000 American deaths each year. Consequently, the rising demand for deep vein thrombosis (DVT) treatment among individuals is a key market driver.
How Is The Deep Vein Thrombosis Market Broken Down By Segment Categories?
The deep vein thrombosis market covered in this report is segmented –
1) By Drug Class: Anticoagulants, Inferior Vena Cava Filters, Other Drug Class
2) By Treatment: Surgery, Drugs, Other Treatments
3) By Mode Of Administration: Injectable, Oral, Other Modes Of Action
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
5) By End User: Hospitals, Homecare, Specialty Clinics, Other End-users
Subsegments:
1) By Anticoagulants: Direct Oral Anticoagulants (DOACs), Vitamin K Antagonists, Low Molecular Weight Heparins, Unfractionated Heparin
2) By Inferior Vena Cava Filters: Retrievable IVC Filters, Permanent IVC Filters, Advanced IVC Filter Systems
3) By Other Drug Class: Thrombolytics, Antiplatelet Agents, Fibrinolytics, Combination Therapy
Which Trends Are Shaping The Deep Vein Thrombosis Market?
Leading companies in the deep vein thrombosis market are concentrating on forming strategic partnerships to enable rapid diagnosis of deep vein thrombosis (DVT) and maximize their market profits. Such collaborations highlight the increasing interest in utilizing AI and machine learning to enhance medical diagnostics, including the swift and precise identification of DVT. For example, in November 2023, ThinkSono Ltd., a UK-based ultrasound AI company focused on diagnosing deep vein thrombosis, partnered with NYU Langone Health, a US-based academic medical center. This partnership aims to launch the first clinical trial of new artificial intelligence (AI)-powered ultrasound software designed for a more rapid and portable diagnosis of deep vein thrombosis (DVT). Through this alliance, the ThinkSono Guidance System technology employs AI to potentially detect DVT more quickly, accurately, and affordably compared to conventional methods. Researchers will use the ThinkSono Guidance System in conjunction with standard ultrasound scanning in patients both with and without DVT. To evaluate and confirm the ThinkSono system’s accuracy, the performance of both approaches will be contrasted. Additionally, medical students from the NYU Grossman School of Medicine will support the trial’s operation as part of the school’s practical research curriculum.
Which Players Are Present In The Deep Vein Thrombosis Market Space?
Major companies operating in the deep vein thrombosis market are Abbott Laboratories, Bristol-Myers Squibb Company, Sanofi-Aventis U.S. LLC, Daiichi Sankyo Company Limited, Novartis AG, Mylan N.V., Bayer AG, Boehringer Ingelheim GmbH, Medtronic PLC, Hikma Pharmaceuticals PLC, Teva Pharmaceutical Industries Ltd., Stryker Corporation, Cook Medical Incorporated, Boston Scientific Corporation, Pfizer Inc., Johnson & Johnson, GlaxoSmithKline plc, Shire Pharmaceuticals, AstraZeneca PLC, Endo International plc
Get The Full Deep Vein Thrombosis Market Report:
https://www.thebusinessresearchcompany.com/report/deep-vein-thrombosis-global-market-report
Which Region Leads The Deep Vein Thrombosis Market In Terms Of Market Share?
North America was the largest region in the deep vein thrombosis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global deep vein thrombosis market report during the forecast period. The regions covered in the deep vein thrombosis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Deep Vein Thrombosis Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/report/deep-vein-thrombosis-global-market-report
Browse Through More Reports Similar to the Global Deep Vein Thrombosis Market 2026, By The Business Research Company
Deep Vein Thrombosis Market Report 2026
https://www.thebusinessresearchcompany.com/report/deep-vein-thrombosis-global-market-report
Venous Thromboembolism Market Report 2026
https://www.thebusinessresearchcompany.com/report/venous-thromboembolism-global-market-report
Thrombophilia Market Report 2026
https://www.thebusinessresearchcompany.com/report/thrombophilia-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model